IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro

IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro

ABSTRACT Increasing evidence indicates that interferon alpha (IFN-α) therapy is an effective treatment option for a subgroup of patients with chronic hepatitis B virus (HBV) infection. It has been confirmed that interferon-induced protein with tetratricopeptide repeats 3 (IFIT3), a member of the int...

Full description

Bibliographic Details
Main Authors: Siyi Xu, Jinlan Huang, Zhen Xun, Shiqi Li, Ya Fu, Ni Lin, Wennan Wu, Tianbin Chen, Can Liu, Qishui Ou
Format: Article
Language:English
Published: American Society for Microbiology 2022-12-01
Series:Microbiology Spectrum
Subjects:
IFIT3
chronic hepatitis B
interferon
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01557-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.01557-22

Similar Items